Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01694186 · ClinicalTrials.gov registry record · Phase 3
Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert
A Phase 3 study of Non-infectious Uveitis, sponsored by EyePoint Pharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 129
- Enrollment target
- 20
- Study locations
NCT01694186 is a Phase 3 study of Non-infectious Uveitis that has completed, run by EyePoint Pharmaceuticals. The registered enrollment target is 129 participants. The trial reports 20 study locations across 14 states.
The verdict
NCT01694186, a Phase 3 study of Non-infectious Uveitis, has completed, sponsored by EyePoint Pharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 129 participants
- Enrollment target
- 20
- Study locations
Study Summary
A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.
Conditions Studied
Interventions
- DRUG FAI insert
- DRUG Sham injection
Study Locations (20)
California
- Retina Vitreaous Associates - Beverly Hills
- Retinal Consultants Medical Group, Inc - Sacramento
- Retina Macula Institute - Torrance
Texas
- Texas Retina Associates - Arlington
- Retina Consultants of Houston - Houston
- Foresight Studies, LLC - San Antonio
Other
- Augenarzte am St. Franziskus Hospital - Münster
- Universitatsklinikum Tubingen - Tübingen
- Bajcsy-Zsilinszky Kórház és Rendelőintézet - Budapest
Colorado
- Retina Consultants of Southern Colorado - Colorado Springs
Illinois
- Northwestern University - Chicago
Kentucky
- Ophthalmology & Visual Sciences - Lexington
Massachusetts
- Ocular Immunology and Uveitis Foundation - Cambridge
Nebraska
- University of Nebraska Medical Center - Omaha
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 129 participants |
| Start Date | 2013-08-02 |
| Est. Completion | 2018-03-26 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01694186
The ClinicalTrials.gov registry entry for NCT01694186 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 129 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is EyePoint Pharmaceuticals, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-infectious Uveitis appearing as the primary indexed condition, and to 2 interventions - of which FAI insert is the first listed.
NCT01694186 reports 20 study locations spanning 14 distinct geographic areas - top geographies include California, Texas, Other.
Frequently Asked Questions
What is clinical trial NCT01694186 about?
NCT01694186 is a clinical study titled "Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert". A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.
What is the current status of trial NCT01694186?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 129 participants. The study started on 2013-08-02. Estimated completion is 2018-03-26.
What conditions does trial NCT01694186 study?
This clinical trial studies the following conditions: Non-infectious Uveitis.
What interventions are being tested in trial NCT01694186?
The interventions under investigation include: FAI insert (DRUG), Sham injection (DRUG).
Who is sponsoring clinical trial NCT01694186?
This trial is sponsored by EyePoint Pharmaceuticals, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01694186 being conducted?
This trial has 20 study locations across California, Colorado, Illinois, Kentucky, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-infectious Uveitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.